Europe Hip Replacement Market Forecast 2025–2033

Europe Hip Replacement Market Overview

According to Renub Research Recent Report Europe Hip Replacement Market was valued at US$ 1.95 billion in 2024 and is projected to reach US$ 2.78 billion by 2033, growing at a CAGR of 4.04% during 2025–2033.

Hip replacement, or hip arthroplasty, involves replacing a damaged hip joint with an artificial implant to relieve pain and restore mobility. The procedure is primarily performed on patients suffering from osteoarthritis, rheumatoid arthritis, avascular necrosis, hip fractures, or other hip-related injuries. Surgeries can be performed through minimally invasive or open techniques, often under general anesthesia.

The market growth is driven by the aging population, increasing hip disorder prevalence, rising healthcare expenditure, advancements in surgical technologies, and growing awareness of joint health and quality of life.

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Free Sample Report

Growth Drivers

1. Technological Advancements

Robotic-assisted surgeries and minimally invasive procedures enhance surgical precision, reduce recovery times, and improve patient outcomes.

Example: In August 2023, Nuffield Health Warwickshire Hospital introduced the Mako robot-assisted surgery system for hip replacements.

Advances in implant materials such as ceramic and titanium components improve durability and reduce complications, increasing patient confidence in hip arthroplasty.

2. Increasing Prevalence of Hip Disorders

Hip osteoarthritis (HOA) is the leading cause of hip pain in the elderly.

Incidence rises with age, particularly over 50, and is exacerbated by obesity and sedentary lifestyles.

Growing demand for effective pain relief and mobility improvement drives hip replacement procedures, sustaining market growth.

3. Rising Awareness and Healthcare Spending

Awareness of joint health and mobility issues is increasing, leading more patients to consider surgical intervention.

Rising healthcare expenditures and reimbursement policies across Europe improve access to hip replacement surgery.

Enhanced surgical techniques and improved implants further encourage adoption, creating a positive feedback loop for market expansion.

Market Challenges

1. High Costs

Hip replacement procedures, including implants, hospitalization, and rehabilitation, are expensive.

In countries with underfunded healthcare or limited insurance coverage, high out-of-pocket costs can restrict access.

Advanced implants and technologies further elevate expenses, limiting market penetration in cost-sensitive regions.

2. Post-Surgery Rehabilitation

Successful recovery depends on extensive physical therapy, which can be time-consuming and costly.

Variability in access to high-quality rehabilitation services, especially in rural areas, may affect outcomes.

Non-compliance or delayed rehabilitation can lead to reduced mobility, complications, or revision surgeries, impacting patient satisfaction and market growth.

Country-Wise Insights

Germany

Largest hip replacement market in Europe due to an aging population and high incidence of osteoarthritis.

Advanced surgical techniques, including robotic-assisted and minimally invasive procedures, improve outcomes and reduce recovery times.

Availability of high-quality implants and strong healthcare infrastructure sustain market leadership.

France

Growth driven by aging demographics and increased awareness of joint health.

Adoption of robotic and minimally invasive surgeries enhances precision and shortens recuperation periods.

Rising healthcare spending and access to medical services support consistent growth.

United Kingdom

Aging population and rising hip disorder prevalence drive demand.

Improvements in surgical techniques and implant technology enhance patient outcomes.

Market growth is challenged by NHS waiting times and increasing private healthcare costs, but rising awareness and disposable incomes encourage adoption.

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Market Segmentation

By Product:

Total Hip Replacement

Partial Hip Replacement

Revision Hip Replacement

By End-User:

Hospitals & Surgery Centers

Orthopedic Clinics

Others

By Country:

France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Russia, Poland, Greece, Norway, Romania, Portugal, Rest of Europe

Competitive Landscape

Key players in the Europe Hip Replacement Market include:

Smith & Nephew PLC – Orthopedic devices and implants

Johnson & Johnson – Hip replacement solutions and surgical instruments

Integra Lifesciences Corporation – Medical devices and joint implants

MicroPort Scientific Corp – Customized hip implants

Zimmer Biomet Holdings Inc – Orthopedic and reconstructive products

Stryker Corporation – Innovative joint replacement technologies

B. Braun Melsungen AG – Advanced orthopedic solutions

Globus Medical Inc. – Hip implants and surgical tools

These companies focus on innovation, digital integration, implant customization, and partnerships with healthcare institutions to expand their footprint in Europe.

Future Outlook

The Europe Hip Replacement Market is expected to grow steadily due to:

Aging demographics and rising hip disorder prevalence

Advancements in surgical techniques and implant technology

Increasing awareness and spending on joint health and mobility

Expansion of healthcare infrastructure and robotic-assisted surgeries

Challenges such as high procedure costs and rehabilitation access require strategic solutions. Companies adopting technological innovations, patient-centered care, and efficient post-operative rehabilitation programs are likely to capture significant market share.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.